
Ozempic-Like Drugs Show Promise in Reducing Chronic Migraines
A pilot study suggests that GLP-1 agonists like liraglutide, originally used for diabetes and weight loss, may significantly reduce the frequency of chronic migraines, potentially through mechanisms independent of weight loss, such as lowering intracranial pressure. Further research is needed to confirm these findings.




